Telehealth company Hims & Hers is pushing the boundaries of drug compounding and testing the limits of regulators.

China, one of the countries affected by the new tariffs, is the world’s largest producer of active pharmaceutical ingredients ...

President Trump’s tariffs on China could increase drug prices and spur shortages across the U.S. as a trade war looms. NBC ...

This would reverse progress toward curbing drug shortages. AstraZeneca scrapped plans to invest $558.3 million in its vaccine ...

But compounding pharmacies face stiffer restrictions when a drug shortage is resolved. Hims & Hers markets compounded versions of Novo Nordisk's semaglutide, a medication that remains in shortage ...

Cencora, a global healthcare company, has expanded its Sure Supply Program to include 200 critical medications, including several oncology treatments, in response to ongoing drug shortages. This marks ...

Cencora (COR) has significantly expanded the number and type of medications available in its sure supply program, a drug shortage mitigation ...

AdvaMed, the largest medical device association globally, urged the Trump administration to exempt medical products from the ...

The shortage of generic chemotherapy drugs cisplatin and carboplatin that began in early 2023 did not increase short-term ...

Chelsee Jensen, PharmD, BCPS, senior pharmacy specialist at Mayo Clinic, suggests that medical providers can reduce patient ...